A Phase 1 Study with ABBV-CLS-484 Alone and in Combination in Subjects with Locally Advanced or Metastatic Tumors," protocol no. M20-431
Clinical Trial Grant
Awarded By
Calico Life Sciences LLC
Start Date
December 9, 2025
End Date
March 31, 2027
Awarded By
Calico Life Sciences LLC
Start Date
December 9, 2025
End Date
March 31, 2027